Tarec C. Galaly-El
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 223 publications
Erratum: High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 27, 2026
Clinical outcomes of patients with diffuse large B-cell lymphoma and concomitant rheumatoid arthritis: a nationwide Danish register-based cohort study.
Journal: EULAR rheumatology open
Published: June 29, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 11, 2026
Impact of Intensified Chemoimmunotherapy Regimens in Aggressive Non-Hodgkin Lymphoma on Reproduction Patterns.
Journal: European journal of haematology
Published: May 14, 2026
Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.
Journal: Haematologica
Published: April 12, 2026
Risk of Bias Associated with Varying Sampling Strategies for External Comparator Cohorts for Single-Arm Trials: Insights from Aggressive Lymphoma.
Journal: Clinical pharmacology and therapeutics
Published: March 30, 2026
First-line immunochemotherapy for indolent lymphoma does not affect muscle volume: a post hoc analysis of 472 patients in long-term remissions from the GALLIUM study.
Journal: Leukemia & lymphoma
Published: March 25, 2026
Beyond maximum grade: key regulatory considerations in adverse event reporting.
Journal: The Lancet. Haematology
Published: March 13, 2026
A real-world comparison of CD20xCD3 bispecific antibodies versus chemotherapy regimens in 3+ line relapsed/refractory diffuse large B cell lymphoma.
Journal: Leukemia & lymphoma
Published: March 11, 2026
Two decades of phase 1 and 2 trials in relapsed or refractory diffuse large B-cell lymphoma.
Journal: The Lancet. Haematology
Published: March 06, 2026
Population-based survival after mantle cell lymphoma in Norway and Denmark: Limited impact of earlier BTKi access.
Journal: British journal of haematology
Published: February 27, 2026
Beyond maximum grade: the role of real-world digital health technologies to capture, predict, and manage treatment toxicity in haematological cancers.
Journal: The Lancet. Haematology
Published: February 18, 2026
Last Updated: 09/26/2026